Back to Journals » International Journal of Nanomedicine » Volume 10 » Issue 1

Coadministration of doxorubicin and etoposide loaded in camel milk phospholipids liposomes showed increased antitumor activity in a murine model

Authors Maswadeh H, N. Aljarbou A, S. Alorainy M, Rahmani A, Khan MA

Received 13 January 2015

Accepted for publication 24 February 2015

Published 13 April 2015 Volume 2015:10(1) Pages 2847—2855


Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 3

Editor who approved publication: Dr Thomas J Webster

Hamzah M Maswadeh,1 Ahmed N Aljarbou,1 Mohammed S Alorainy,2 Arshad H Rahmani,3 Masood A Khan3

1Department of Pharmaceutics, College of Pharmacy, 2Department of Pharmacology and Therapeutics, College of Medicine, 3College of Applied Medical Sciences, Qassim University, Buraydah, Kingdom of Saudi Arabia

Abstract: Small unilamellar vesicles from camel milk phospholipids (CML) mixture or from 1,2 dipalmitoyl-sn-glycero-3-phosphatidylcholine (DPPC) were prepared, and anticancer drugs doxorubicin (Dox) or etoposide (ETP) were loaded. Liposomal formulations were used against fibrosarcoma in a murine model. Results showed a very high percentage of Dox encapsulation (~98%) in liposomes (Lip) prepared from CML-Lip or DPPC-Lip, whereas the percentage of encapsulations of ETP was on the lower side, 22% of CML-Lip and 18% for DPPC-Lip. Differential scanning calorimetry curves show that Dox enhances the lamellar formation in CML-Lip, whereas ETP enhances the nonlamellar formation. Differential scanning calorimetry curves also showed that the presence of Dox and ETP together into DPPC-Lip produced the interdigitation effect. The in vivo anticancer activity of liposomal formulations of Dox or ETP or a combination of both was assessed against benzopyrene (BAP)-induced fibrosarcoma in a murine model. Tumor-bearing mice treated with a combination of Dox and ETP loaded into CML-Lip showed increased survival and reduced tumor growth compared to other groups, including the combination of Dox and ETP in DPPC-Lip. Fibrosarcoma-bearing mice treated with a combination of free (Dox + ETP) showed much higher tumor growth compared to those groups treated with CML-Lip-(Dox + ETP) or DPPC-Lip-(Dox + ETP). Immunohistochemical study was also performed to show the expression of tumor-suppressor PTEN, and it was found that the tumor tissues from the group of mice treated with a combination of free (Dox + ETP) showed greater loss of cytoplasmic PTEN than tumor tissues obtained from the groups of mice treated with CML-Lip-(Dox + ETP) or DPPC-Lip-(Dox + ETP).

Keywords: combination chemotherapy, BAP-induced tumors, immunohistochemistry

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]


Readers of this article also read:

Enhanced pharmacological activity of Vitamin B12 and Penicillin as nanoparticles

Yariv I, Lipovsky A, Gedanken A, Lubart R, Fixler D

International Journal of Nanomedicine 2015, 10:3593-3601

Published Date: 15 May 2015

CdTe quantum dots induce activation of human platelets: implications for nanoparticle hemocompatibility

Samuel SP, Santos-Martinez MJ, Medina C, Jain N, Radomski MW, Prina-Mello A, Volkov Y

International Journal of Nanomedicine 2015, 10:2723-2734

Published Date: 2 April 2015

Enhanced local bioavailability of single or compound drugs delivery to the inner ear through application of PLGA nanoparticles via round window administration

Cai H, Wen X, Wen L, Tirelli N, Zhang X, Zhang Y, Su H, Yang F, Chen G

International Journal of Nanomedicine 2014, 9:5591-5601

Published Date: 1 December 2014

Carboxyl-modified single-wall carbon nanotubes improve bone tissue formation in vitro and repair in an in vivo rat model

Barrientos-Durán A, Carpenter EM, zur Nieden NI, Malinin TI, Rodríguez-Manzaneque JC, Zanello LP

International Journal of Nanomedicine 2014, 9:4277-4291

Published Date: 9 September 2014

Green synthesis of gold nanoparticles using plant extracts as reducing agents

Elia P, Zach R, Hazan S, Kolusheva S, Porat Z, Zeiri Y

International Journal of Nanomedicine 2014, 9:4007-4021

Published Date: 20 August 2014

Comparative study of bioactivity of collagen scaffolds coated with graphene oxide and reduced graphene oxide

Kanayama I, Miyaji H, Takita H, Nishida E, Tsuji M, Fugetsu B, Sun L, Inoue K, Ibara A, Akasaka T, Sugaya T, Kawanami M

International Journal of Nanomedicine 2014, 9:3363-3373

Published Date: 11 July 2014

Novel flower-shaped albumin particles as controlled-release carriers for drugs to penetrate the round-window membrane

Yu Z, Yu M, Zhou Z, Zhang Z, Du B, Xiong Q

International Journal of Nanomedicine 2014, 9:3193-3201

Published Date: 1 July 2014

Chlorotoxin-conjugated graphene oxide for targeted delivery of an anticancer drug

Wang H, Gu W, Xiao N, Ye L, Xu Q

International Journal of Nanomedicine 2014, 9:1433-1442

Published Date: 18 March 2014